If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Mounjaro™ (tirzepatide) injection
2.5 mg/5 mg/7.5 mg/10 mg/12.5 mg/15 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
How does tirzepatide compare with oral semaglutide?
Lilly is not currently conducting trials comparing tirzepatide with oral semaglutide.
See important safety information, including boxed warning, in the attached prescribing information.
Eli Lilly and Company is not currently conducting phase 3 clinical trials assessing the efficacy and safety of tirzepatide compared with oral semaglutide as a treatment to improve glycemic control in people with type 2 diabetes (T2D).
Enclosed Prescribing Information
Date of Last Review: May 25, 2022